메뉴 건너뛰기




Volumn 7, Issue 3, 2006, Pages 297-305

Fungal infections in solid organ transplantation

Author keywords

Amphotericin B; Aspergillus; Candida; Caspofungin; Fungal infections; Heart transplant; Immunosuppression; Kidney transplant; Liver transplant; Lung transplant; Opportunistic infections; Organ transplant; Voriconazole

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID; CYCLOSPORIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; GANCICLOVIR; ITRACONAZOLE; KETOCONAZOLE; RAPAMYCIN; TSUKUBAENOLIDE; VORICONAZOLE;

EID: 33144468942     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.7.3.297     Document Type: Review
Times cited : (62)

References (78)
  • 1
    • 1442314095 scopus 로고    scopus 로고
    • Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS
    • DHARNIDHARKA VR, STABLEIN DM, HARMON WE: Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS. Am. J. Transplant. (2004) 4:384-389.
    • (2004) Am. J. Transplant. , vol.4 , pp. 384-389
    • Dharnidharka, V.R.1    Stablein, D.M.2    Harmon, W.E.3
  • 2
    • 0035684413 scopus 로고    scopus 로고
    • Hospitalizations for fungal infections after renal transplantation in the United States
    • ABBOTT KC, HYPOLITE I, POROPATICH RK et al.: Hospitalizations for fungal infections after renal transplantation in the United States. Transpl. Infect. Dis. (2001) 3:203-211.
    • (2001) Transpl. Infect. Dis. , vol.3 , pp. 203-211
    • Abbott, K.C.1    Hypolite, I.2    Poropatich, R.K.3
  • 3
    • 0037235092 scopus 로고    scopus 로고
    • Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
    • SINGH N, AVERY RK, MUNOZ P et al.: Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin. Infect. Dis. (2003) 36:46-52.
    • (2003) Clin. Infect. Dis. , vol.36 , pp. 46-52
    • Singh, N.1    Avery, R.K.2    Munoz, P.3
  • 4
    • 0037080599 scopus 로고    scopus 로고
    • Trends in invasive fungal infections in liver transplant recipients: Correlation with evolution in transplantation practices
    • SINGH N, WAGENER MM, MARINO IR, GAYOWSKI T: Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation (2002) 73:63-67.
    • (2002) Transplantation , vol.73 , pp. 63-67
    • Singh, N.1    Wagener, M.M.2    Marino, I.R.3    Gayowski, T.4
  • 5
    • 0035889523 scopus 로고    scopus 로고
    • Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices
    • SINGH N: Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin. Infect. Dis. (2001) 33:1692-1696.
    • (2001) Clin. Infect. Dis. , vol.33 , pp. 1692-1696
    • Singh, N.1
  • 6
    • 20844461687 scopus 로고    scopus 로고
    • Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study
    • GAVALDA J, LEN O, SAN JUAN R et al.: Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin. Infect. Dis. (2005) 41:52-59.
    • (2005) Clin. Infect. Dis. , vol.41 , pp. 52-59
    • Gavalda, J.1    Len, O.2    San Juan, R.3
  • 7
    • 0030792873 scopus 로고    scopus 로고
    • The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients
    • Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland
    • GEORGE MJ, SNYDMAN DR, WERNER BG et al.: The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am. J. Med. (1997) 103:106-113.
    • (1997) Am. J. Med. , vol.103 , pp. 106-113
    • George, M.J.1    Snydman, D.R.2    Werner, B.G.3
  • 8
    • 0034720716 scopus 로고    scopus 로고
    • Human herpesvirus-6 in liver transplant recipients: Role in pathogenesis of fungal infections, neurologic complications, and outcome
    • ROGERS J, ROHAL S, CARRIGAN DR et al.: Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation (2000) 69:2566-2573.
    • (2000) Transplantation , vol.69 , pp. 2566-2573
    • Rogers, J.1    Rohal, S.2    Carrigan, D.R.3
  • 9
    • 0034037337 scopus 로고    scopus 로고
    • Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
    • EINSELE H, HEBART H, KAUFFMANN-SCHNEIDER C et al.: Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant. (2000) 25:757-763.
    • (2000) Bone Marrow Transplant. , vol.25 , pp. 757-763
    • Einsele, H.1    Hebart, H.2    Kauffmann-Schneider, C.3
  • 10
    • 3242714014 scopus 로고    scopus 로고
    • Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system
    • MUNOZ P, GUINEA J, PELAEZ T et al.: Nosocomial invasive aspergillosis in a heart transplant patient acquired during a break in the HEPA air filtration system. Transpl. Infect. Dis. (2004) 6:50-54.
    • (2004) Transpl. Infect. Dis. , vol.6 , pp. 50-54
    • Munoz, P.1    Guinea, J.2    Pelaez, T.3
  • 11
    • 19044375724 scopus 로고    scopus 로고
    • Cleaning patient shower facilities: A novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds
    • ANAISSIE EJ, STRATTON SL, DIGNANI MC et al.: Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin. Infect. Dis. (2002) 35:E86-E88.
    • (2002) Clin. Infect. Dis. , vol.35
    • Anaissie, E.J.1    Stratton, S.L.2    Dignani, M.C.3
  • 12
    • 0037090138 scopus 로고    scopus 로고
    • Contamination of hospital water with Aspergillus fumigatus and other molds
    • WARRIS A, VOSS A, ABRAHAMSEN TG, VERWEIJ PE: Contamination of hospital water with Aspergillus fumigatus and other molds. Clin. Infect. Dis. (2002) 34:1159-1160.
    • (2002) Clin. Infect. Dis. , vol.34 , pp. 1159-1160
    • Warris, A.1    Voss, A.2    Abrahamsen, T.G.3    Verweij, P.E.4
  • 13
    • 0035503195 scopus 로고    scopus 로고
    • Nosocomial aspergillosis is waterborne
    • ANAISSIE EJ, COSTA SF: Nosocomial aspergillosis is waterborne. Clin. Infect. Dis. (2001) 33:1546-1548.
    • (2001) Clin. Infect. Dis. , vol.33 , pp. 1546-1548
    • Anaissie, J.1    Costa, S.F.2
  • 14
    • 1942469960 scopus 로고    scopus 로고
    • Risk factors of invasive aspergillosis after heart transplantation: Protective role of oral itraconazole prophylaxis
    • MUNOZ P, RODRIGUEZ C, BOUZA E et al.: Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am. J. Transplant. (2004) 4:636-643.
    • (2004) Am. J. Transplant. , vol.4 , pp. 636-643
    • Munoz, P.1    Rodriguez, C.2    Bouza, E.3
  • 15
    • 0037774784 scopus 로고    scopus 로고
    • Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: Prospective, multicenter, case-controlled study
    • HUSAIN S, TOLLEMAR J, DOMINGUEZ EA et al.: Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation (2003) 75:2023-2029.
    • (2003) Transplantation , vol.75 , pp. 2023-2029
    • Husain, S.1    Tollemar, J.2    Dominguez, E.A.3
  • 16
    • 0036852162 scopus 로고    scopus 로고
    • Risk factors for invasive aspergillosis in liver transplant recipients
    • FORTUN J, MARTIN-DAVILA P, MORENO S et al.: Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transplantation (2002) 8:1065-1070.
    • (2002) Liver Transplantation , vol.8 , pp. 1065-1070
    • Fortun, J.1    Martin-Davila, P.2    Moreno, S.3
  • 17
    • 0029811528 scopus 로고    scopus 로고
    • Primary liver transplantation without transfusion of red blood cells
    • CACCIARELLI TV, KEEFFE EB, MOORE DH et al.: Primary liver transplantation without transfusion of red blood cells. Surgery (1996) 120:698-704.
    • (1996) Surgery , vol.120 , pp. 698-704
    • Cacciarelli, T.V.1    Keeffe, E.B.2    Moore, D.H.3
  • 18
    • 0030811786 scopus 로고    scopus 로고
    • Biliary reconstruction without T tubes or stents in liver transplantation: Report of 502 consecutive cases
    • VERRAN DJ, ASFAR SK, GHENT CN, GRANT DR, WALL WJ: Biliary reconstruction without T tubes or stents in liver transplantation: report of 502 consecutive cases. Liver Transpl. Surg. (1997) 3:365-373.
    • (1997) Liver Transpl. Surg. , vol.3 , pp. 365-373
    • Verran, D.J.1    Asfar, S.K.2    Ghent, C.N.3    Grant, D.R.4    Wall, W.J.5
  • 19
    • 0035082533 scopus 로고    scopus 로고
    • Infectious complications in patients with the Novacor left ventricular assist system
    • GROSSI P, DALLA GD, PAGANI F et al.: Infectious complications in patients with the Novacor left ventricular assist system. Transplant. Proc. (2001) 33:1969-1971.
    • (2001) Transplant. Proc. , vol.33 , pp. 1969-1971
    • Grossi, P.1    Dalla, G.D.2    Pagani, F.3
  • 20
    • 0028789578 scopus 로고
    • Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment
    • GOLDSTEIN DJ, EL-AMIR NG, ASHTON RC Jr et al.: Fungal infections in left ventricular assist device recipients. Incidence, prophylaxis, and treatment. ASAIO J (1995) 41:873-875.
    • (1995) ASAIO J , vol.41 , pp. 873-875
    • Goldstein, D.J.1    El-Amir, N.G.2    Ashton Jr., R.C.3
  • 22
    • 0035125641 scopus 로고    scopus 로고
    • Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature
    • MEHRAD B, PACIOCCO G, MARTINEZ FJ et al.: Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest (2001) 119:169-175.
    • (2001) Chest , vol.119 , pp. 169-175
    • Mehrad, B.1    Paciocco, G.2    Martinez, F.J.3
  • 23
    • 0031956205 scopus 로고    scopus 로고
    • Cytomegalovirus infection is a factor for invasive aspergillosis in lung transplant recipients
    • HUSNI RN, GORDON SM, LONGWORTH DL et al.: Cytomegalovirus infection is a factor for invasive aspergillosis in lung transplant recipients. Clin. Infect. Dis. (1998) 26:753-755.
    • (1998) Clin. Infect. Dis. , vol.26 , pp. 753-755
    • Husni, R.N.1    Gordon, S.M.2    Longworth, D.L.3
  • 24
    • 0030752434 scopus 로고    scopus 로고
    • Saprophytic fungal infections and lung transplantation-revisited
    • PARADOWSKI LJ: Saprophytic fungal infections and lung transplantation-revisited. J. Heart Lung Transplant. (1997) 16:524-531.
    • (1997) J. Heart Lung Transplant. , vol.16 , pp. 524-531
    • Paradowski, L.J.1
  • 25
    • 0030005016 scopus 로고    scopus 로고
    • Aspergillus infection in single and double lung transplant recipients
    • WESTNEY GE, KESTEN S, DE HOYOS A et al.: Aspergillus infection in single and double lung transplant recipients. Transplantation (1996) 61:915-919.
    • (1996) Transplantation , vol.61 , pp. 915-919
    • Westney, G.E.1    Kesten, S.2    De Hoyos, A.3
  • 26
    • 12944291020 scopus 로고    scopus 로고
    • Aspergillus infections in transplant recipients
    • SINGH N, PATERSON DL: Aspergillus infections in transplant recipients. Clin. Microbiol. Rev. (2005) 18:44-69.
    • (2005) Clin. Microbiol. Rev. , vol.18 , pp. 44-69
    • Singh, N.1    Paterson, D.L.2
  • 27
    • 0037337591 scopus 로고    scopus 로고
    • Aspergillus infections after lung transplantation: Clinical differences in type of transplant and implications for management
    • SINGH N, HUSAIN S: Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J. Heart Lung Transplant. (2003) 22:258-266.
    • (2003) J. Heart Lung Transplant. , vol.22 , pp. 258-266
    • Singh, N.1    Husain, S.2
  • 28
    • 0141863188 scopus 로고    scopus 로고
    • Echinocandin antifungal drugs
    • DENNING DW: Echinocandin antifungal drugs. Lancet (2003) 362:1142-1151.
    • (2003) Lancet , vol.362 , pp. 1142-1151
    • Denning, D.W.1
  • 29
    • 0037137576 scopus 로고    scopus 로고
    • Comparison of caspofungin and amphotericin B for invasive candidiasis
    • MORA-DUARTE J, BETTS R, ROTSTEIN C et al.: Comparison of caspofungin and amphotericin B for invasive candidiasis. N. Engl. J. Med. (2002) 347:2020-2029.
    • (2002) N. Engl. J. Med. , vol.347 , pp. 2020-2029
    • Mora-Duarte, J.1    Betts, R.2    Rotstein, C.3
  • 30
    • 2442670343 scopus 로고    scopus 로고
    • Second-line therapy with caspofungin for mucosal or invasive candidiasis: Results from the caspofungin compassionate-use study
    • KARTSONIS NA, SAAH A, LIPKA CJ, TAYLOR A, SABLE CA: Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study. J. Antimicrob. Chemother. (2004) 53:878-881.
    • (2004) J. Antimicrob. Chemother. , vol.53 , pp. 878-881
    • Kartsonis, N.A.1    Saah, A.2    Lipka, C.J.3    Taylor, A.4    Sable, C.A.5
  • 31
    • 0042410872 scopus 로고    scopus 로고
    • Global distribution and outcomes for Candida species causing invasive candidiasis: Results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis
    • COLOMBO AL, PERFECT J, DINUBILE M et al.: Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. (2003) 22:470-474.
    • (2003) Eur. J. Clin. Microbiol. Infect. Dis. , vol.22 , pp. 470-474
    • Colombo, A.L.1    Perfect, J.2    Dinubile, M.3
  • 33
    • 33144458567 scopus 로고    scopus 로고
    • Cancidas (caspofungin acetate). Summary of product characteristics
    • Document European Public Assessment Report, The European Agency for the Evaluation of Medicinal Products
    • Cancidas (caspofungin acetate). Summary of product characteristics. Document European Public Assessment Report, The European Agency for the Evaluation of Medicinal Products, (2005).
    • (2005)
  • 34
    • 0036073337 scopus 로고    scopus 로고
    • Safety and tolerability of caspofungin acetate in the treatment of fungal infections
    • SABLE CA, NGUYEN BY, CHODAKEWITZ JA, DINUBILE MJ: Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl. Infect Dis. (2002) 4:25-30.
    • (2002) Transpl. Infect Dis. , vol.4 , pp. 25-30
    • Sable, C.A.1    Nguyen, B.Y.2    Chodakewitz, J.A.3    Dinubile, M.J.4
  • 35
    • 0346338386 scopus 로고    scopus 로고
    • Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection
    • ANTTILA VJ, PIILONEN A, VALTONEN M: Co-administration of caspofungin and cyclosporine to a kidney transplant patient with pulmonary Aspergillus infection. Scand. J. Infect. Dis. (2003) 35:893-894.
    • (2003) Scand. J. Infect. Dis. , vol.35 , pp. 893-894
    • Anttila, V.J.1    Piilonen, A.2    Valtonen, M.3
  • 36
    • 19944397088 scopus 로고    scopus 로고
    • Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A
    • MARR KA, HACHEM R, PAPANICOLAOU G et al.: Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A. Transpl. Infect Dis. (2004) 6:110-116.
    • (2004) Transpl. Infect Dis. , vol.6 , pp. 110-116
    • Marr, K.A.1    Hachem, R.2    Papanicolaou, G.3
  • 37
    • 3543095658 scopus 로고    scopus 로고
    • Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections
    • SANZ-RODRIGUEZ C, LOPEZ-DUARTE M, JURADO M et al.: Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections. Bone Marrow Transplant. (2004) 34:13-20.
    • (2004) Bone Marrow Transplant. , vol.34 , pp. 13-20
    • Sanz-Rodriguez, C.1    Lopez-Duarte, M.2    Jurado, M.3
  • 38
    • 0033037922 scopus 로고    scopus 로고
    • Invasive aspergillosis in transplant recipients
    • PATERSON DL, SINGH N: Invasive aspergillosis in transplant recipients. Medicine (1999) 78:123-138.
    • (1999) Medicine , vol.78 , pp. 123-138
    • Paterson, D.L.1    Singh, N.2
  • 39
    • 0030931525 scopus 로고    scopus 로고
    • Invasive aspergillosis in liver transplant recipients in the 1990s
    • SINGH N, ARNOW PM, BONHAM A et al.: Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation (1997) 64:716-720.
    • (1997) Transplantation , vol.64 , pp. 716-720
    • Singh, N.1    Arnow, P.M.2    Bonham, A.3
  • 40
    • 0034662016 scopus 로고    scopus 로고
    • Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: A multicenter retrospective study
    • Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients
    • GROSSI P, FARINA C, FIOCCHI R, DALLA GD: Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation (2000) 70:112-116.
    • (2000) Transplantation , vol.70 , pp. 112-116
    • Grossi, P.1    Farina, C.2    Fiocchi, R.3    Dalla, G.D.4
  • 41
    • 0141887303 scopus 로고    scopus 로고
    • Invasive aspergillosis in the setting of cardiac transplantation
    • MONTOYA JG, CHAPARRO SV, CELIS D et al.: Invasive aspergillosis in the setting of cardiac transplantation. Clin. Infect. Dis. (2003) 37(Suppl. 3):S281-S292.
    • (2003) Clin. Infect. Dis. , vol.37 , Issue.SUPPL. 3
    • Montoya, J.G.1    Chaparro, S.V.2    Celis, D.3
  • 42
    • 0036431729 scopus 로고    scopus 로고
    • Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation
    • NUNLEY DR, GAL AA, VEGA JD et al.: Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation. Chest (2002) 122:1185-1191.
    • (2002) Chest , vol.122 , pp. 1185-1191
    • Nunley, D.R.1    Gal, A.A.2    Vega, J.D.3
  • 43
    • 0037369002 scopus 로고    scopus 로고
    • Fungal infections in the recipients of solid organ transplantation
    • SINGH N: Fungal infections in the recipients of solid organ transplantation. Infect. Dis. Clin. North Am. (2003) 17:113-134.
    • (2003) Infect. Dis. Clin. North Am. , vol.17 , pp. 113-134
    • Singh, N.1
  • 44
    • 0027394103 scopus 로고
    • CNS aspergillosis in organ transplantation: A clinicopathological study
    • TORRE-CISNEROS J, LOPEZ OL, KUSNE S et al.: CNS aspergillosis in organ transplantation: a clinicopathological study. J. Neurol. Neurosurg. Psy. (1993) 56:188-193.
    • (1993) J. Neurol. Neurosurg. Psy. , vol.56 , pp. 188-193
    • Torre-Cisneros, J.1    Lopez, O.L.2    Kusne, S.3
  • 45
    • 0347723792 scopus 로고    scopus 로고
    • Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients
    • KWAK EJ, HUSAIN S, OBMAN A et al.: Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J. Clin. Microbiol. (2004) 42:435-438.
    • (2004) J. Clin. Microbiol. , vol.42 , pp. 435-438
    • Kwak, E.J.1    Husain, S.2    Obman, A.3
  • 46
    • 0027945730 scopus 로고
    • Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus
    • LATGE JP, KOBAYASHI H, DEBEAUPUIS JP et al.: Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect. Immun. (1994) 62:5424-5433.
    • (1994) Infect. Immun. , vol.62 , pp. 5424-5433
    • Latge, J.P.1    Kobayashi, H.2    Debeaupuis, J.P.3
  • 47
    • 0032856762 scopus 로고    scopus 로고
    • Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis
    • MAERTENS J, VERHAEGEN J, DEMUYNCK H et al.: Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J. Clin. Microbiol. (1999) 37:3223-3228.
    • (1999) J. Clin. Microbiol. , vol.37 , pp. 3223-3228
    • Maertens, J.1    Verhaegen, J.2    Demuynck, H.3
  • 48
    • 0028821064 scopus 로고
    • A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis
    • STYNEN D, GORIS A, SARFATI J, LATGE JP: A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J. Clin. Microbiol. (1995) 33:497-500.
    • (1995) J. Clin. Microbiol. , vol.33 , pp. 497-500
    • Stynen, D.1    Goris, A.2    Sarfati, J.3    Latge, J.P.4
  • 49
    • 0035863167 scopus 로고    scopus 로고
    • Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients
    • FORTUN J, MARTIN-DAVILA P, ALVAREZ ME et al.: Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation (2001) 71:145-149.
    • (2001) Transplantation , vol.71 , pp. 145-149
    • Fortun, J.1    Martin-Davila, P.2    Alvarez, M.E.3
  • 50
    • 0344666747 scopus 로고    scopus 로고
    • False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam
    • SULAHIAN A, TOURATIER S, RIBAUD P: False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N. Engl. J. Med. (2003) 349:2366-2367.
    • (2003) N. Engl. J. Med. , vol.349 , pp. 2366-2367
    • Sulahian, A.1    Touratier, S.2    Ribaud, P.3
  • 51
    • 0037043655 scopus 로고    scopus 로고
    • Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
    • HERBRECHT R, DENNING DW, PATTERSON TF et al.: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N. Engl. J. Med. (2002) 347:408-415.
    • (2002) N. Engl. J. Med. , vol.347 , pp. 408-415
    • Herbrecht, R.1    Denning, D.W.2    Patterson, T.F.3
  • 52
    • 0037897443 scopus 로고    scopus 로고
    • Invasive aspergillosis in liver transplant recipients: Outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B
    • LINDEN PK, COLEY K, FONTES P, FUNG JJ, KUSNE S: Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Clin. Infect. Dis. (2003) 37:17-25.
    • (2003) Clin. Infect. Dis. , vol.37 , pp. 17-25
    • Linden, P.K.1    Coley, K.2    Fontes, P.3    Fung, J.J.4    Kusne, S.5
  • 53
    • 0036720272 scopus 로고    scopus 로고
    • Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes
    • VENKATARAMANAN R, ZANG S, GAYOWSKI T, SINGH N: Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob. Agents Chemother. (2002) 46:3091-3093.
    • (2002) Antimicrob. Agents Chemother. , vol.46 , pp. 3091-3093
    • Venkataramanan, R.1    Zang, S.2    Gayowski, T.3    Singh, N.4
  • 54
    • 0036532203 scopus 로고    scopus 로고
    • Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
    • MARR KA, CARTER RA, CRIPPA F, WALD A, COREY L: Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. (2002) 34:909-917.
    • (2002) Clin. Infect. Dis. , vol.34 , pp. 909-917
    • Marr, K.A.1    Carter, R.A.2    Crippa, F.3    Wald, A.4    Corey, L.5
  • 55
    • 0035341392 scopus 로고    scopus 로고
    • Invasive mold infections in allogeneic bone marrow transplant recipients
    • BADDLEY JW, STROUD TP, SALZMAN D, PAPPAS PG: Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. (2001) 32:1319-1324.
    • (2001) Clin. Infect. Dis. , vol.32 , pp. 1319-1324
    • Baddley, J.W.1    Stroud, T.P.2    Salzman, D.3    Pappas, P.G.4
  • 56
    • 4344560388 scopus 로고    scopus 로고
    • Invasive Zygomycosis in hematopoietic stem cell transplnat recipients receiving voriconazole prophylaxis
    • SIWEK GT, DODGSON KJ, DE MAGALHAES-SILVERMAN M et al.: Invasive Zygomycosis in hematopoietic stem cell transplnat recipients receiving voriconazole prophylaxis. Clin. Infect. Dis. (2004) 39:584-587.
    • (2004) Clin. Infect. Dis. , vol.39 , pp. 584-587
    • Siwek, G.T.1    Dodgson, K.J.2    De Magalhaes-Silverman, M.3
  • 58
    • 0041766322 scopus 로고    scopus 로고
    • Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi
    • HUSAIN S, ALEXANDER BD, MUNOZ P et al.: Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin. Infect. Dis. (2003) 37:221-229.
    • (2003) Clin. Infect. Dis. , vol.37 , pp. 221-229
    • Husain, S.1    Alexander, B.D.2    Munoz, P.3
  • 59
    • 0035347637 scopus 로고    scopus 로고
    • Cryptococcus neoformans infection in organ transplant recipients: Variables influencing clinical characteristics and outcome
    • HUSAIN S, WAGENER MM, SINGH N: Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg. Infect. Dis. (2001) 7:375-381.
    • (2001) Emerg. Infect. Dis. , vol.7 , pp. 375-381
    • Husain, S.1    Wagener, M.M.2    Singh, N.3
  • 60
    • 0031028176 scopus 로고    scopus 로고
    • The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein
    • ODOM A, DEL PM, PERFECT J, HEITMAN J: The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob. Agents Chemother. (1997) 41:156-161.
    • (1997) Antimicrob. Agents Chemother. , vol.41 , pp. 156-161
    • Odom, A.1    Del, P.M.2    Perfect, J.3    Heitman, J.4
  • 61
    • 0031934615 scopus 로고    scopus 로고
    • Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen
    • SINGH N, GAYOWSKI T, MARINO IR: Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen. Transpl. Int. (1998) 11:63-65.
    • (1998) Transpl. Int. , vol.11 , pp. 63-65
    • Singh, N.1    Gayowski, T.2    Marino, I.R.3
  • 62
    • 0036936783 scopus 로고    scopus 로고
    • Antifungal prophylaxis in liver transplant recipients: A randomized placebo-controlled study
    • BIANCOFIORE G, BINDI ML, BALDASSARRI R et al.: Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study. Transpl. Int. (2002) 15:341-347.
    • (2002) Transpl. Int. , vol.15 , pp. 341-347
    • Biancofiore, G.1    Bindi, M.L.2    Baldassarri, R.3
  • 63
    • 0036966931 scopus 로고    scopus 로고
    • Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients
    • MARINO IR, PANARELLO G, SINGH N: Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients. Transpl. Infect. Dis. (2002) 4:226-227.
    • (2002) Transpl. Infect. Dis. , vol.4 , pp. 226-227
    • Marino, I.R.1    Panarello, G.2    Singh, N.3
  • 64
    • 0031845924 scopus 로고    scopus 로고
    • The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients
    • VAN BURIK JH, LEISENRING W, MYERSON D et al.: The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. Medicine (1998) 77:246-254.
    • (1998) Medicine , vol.77 , pp. 246-254
    • Van Burik, J.H.1    Leisenring, W.2    Myerson, D.3
  • 65
    • 0026597735 scopus 로고
    • A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
    • GOODMAN JL, WINSTON DJ, GREENFIELD RA et al.: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. (1992) 326:845-851.
    • (1992) N. Engl. J. Med. , vol.326 , pp. 845-851
    • Goodman, J.L.1    Winston, D.J.2    Greenfield, R.A.3
  • 66
    • 0033030924 scopus 로고    scopus 로고
    • Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation
    • LORF T, BRAUN F, RUCHEL R et al.: Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation. Mycoses (1999) 42:47-53.
    • (1999) Mycoses , vol.42 , pp. 47-53
    • Lorf, T.1    Braun, F.2    Ruchel, R.3
  • 67
    • 0035870741 scopus 로고    scopus 로고
    • Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy
    • SINGH N, PATERSON DL, GAYOWSKI T, WAGENER MM, MARINO IR: Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation (2001) 71:910-913.
    • (2001) Transplantation , vol.71 , pp. 910-913
    • Singh, N.1    Paterson, D.L.2    Gayowski, T.3    Wagener, M.M.4    Marino, I.R.5
  • 68
    • 0033812708 scopus 로고    scopus 로고
    • Targeted prophylaxis with amphotericin B lipid complex in liver transplantation
    • SINGHAL S, ELLIS RW, JONES SG et al.: Targeted prophylaxis with amphotericin B lipid complex in liver transplantation. Liver Transplantation (2000) 6:588-595.
    • (2000) Liver Transplantation , vol.6 , pp. 588-595
    • Singhal, S.1    Ellis, R.W.2    Jones, S.G.3
  • 69
    • 10744231098 scopus 로고    scopus 로고
    • Prevention of invasive fungal infections in liver transplant recipients: The role of prophylaxis with lipid formulations of amphotericin B in high-risk patients
    • FORTUN J, MARTIN-DAVILA P, MORENO S et al.: Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J. Antimicrob. Chemother. (2003) 52:813-819.
    • (2003) J. Antimicrob. Chemother. , vol.52 , pp. 813-819
    • Fortun, J.1    Martin-Davila, P.2    Moreno, S.3
  • 70
    • 0037326390 scopus 로고    scopus 로고
    • Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species
    • KONTOYIANNIS DP, LEWIS RE, OSHEROV N, ALBERT ND, MAY GS: Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J. Antimicrob. Chemother. (2003) 51:313-316.
    • (2003) J. Antimicrob. Chemother. , vol.51 , pp. 313-316
    • Kontoyiannis, D.P.1    Lewis, R.E.2    Osherov, N.3    Albert, N.D.4    May, G.S.5
  • 71
    • 19444376971 scopus 로고    scopus 로고
    • Drug metabolism and variability among patients in drug response
    • WILKINSON GR: Drug metabolism and variability among patients in drug response. N. Engl. J. Med. (2005) 352:2211-2221.
    • (2005) N. Engl. J. Med. , vol.352 , pp. 2211-2221
    • Wilkinson, G.R.1
  • 72
    • 0347131358 scopus 로고    scopus 로고
    • Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients
    • FLOREA NR, CAPITANO B, NIGHTINGALE CH et al.: Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients. Transplant. Proc. (2003) 35:2873-2877.
    • (2003) Transplant. Proc. , vol.35 , pp. 2873-2877
    • Florea, N.R.1    Capitano, B.2    Nightingale, C.H.3
  • 73
    • 0028845453 scopus 로고
    • Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: A prospective randomized study
    • SOBH M, EL-AGROUDY A, MOUSTAFA F et al.: Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: a prospective randomized study. Am. J. Nephr. (1995) 15:493-499.
    • (1995) Am. J. Nephr. , vol.15 , pp. 493-499
    • Sobh, M.1    El-Agroudy, A.2    Moustafa, F.3
  • 74
    • 0029089702 scopus 로고
    • Ketoconazole to reduce the need for cyclosporine after cardiac transplantation
    • KEOGH A, SPRATT P, MCCOSKER C et al.: Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N. Engl. J. Med. (1995) 333:628-633.
    • (1995) N. Engl. J. Med. , vol.333 , pp. 628-633
    • Keogh, A.1    Spratt, P.2    Mccosker, C.3
  • 75
    • 0030898349 scopus 로고    scopus 로고
    • Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
    • REICHENSPURNER H, GAMBERG P, NITSCHKE M et al.: Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant. Proc. (1997) 29:627-28.
    • (1997) Transplant. Proc. , vol.29 , pp. 627-628
    • Reichenspurner, H.1    Gamberg, P.2    Nitschke, M.3
  • 76
    • 0037572197 scopus 로고    scopus 로고
    • Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients
    • MONFORTE V, ROMAN A, GAVALDA J et al.: Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation (2003) 75:1571-1574.
    • (2003) Transplantation , vol.75 , pp. 1571-1574
    • Monforte, V.1    Roman, A.2    Gavalda, J.3
  • 77
    • 0035881350 scopus 로고    scopus 로고
    • Safety of aerosolized amphotericin B lipid complex in lung transplant recipients
    • PALMER SM, DREW RH, WHITEHOUSE JD et al.: Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation (2001) 72:545-548.
    • (2001) Transplantation , vol.72 , pp. 545-548
    • Palmer, S.M.1    Drew, R.H.2    Whitehouse, J.D.3
  • 78
    • 0742287242 scopus 로고    scopus 로고
    • Comparative safety of amphotericin B lipid complex amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients
    • DREW RH, DODDS AE, BENJAMIN DK Jr et al.: Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation (2004) 77:232-237.
    • (2004) Transplantation , vol.77 , pp. 232-237
    • Drew, R.H.1    Dodds, A.E.2    Benjamin Jr., D.K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.